Elucidating the connections between DBC1, HDAC3 and Rev-erbs may have implications for the pathogenesis and treatment of metabolic diseases like obesity, diabetes, liver steatosis, metabolic syndrome and cancer. This evidence concerns the gene CCAR2 and metabolic syndrome.